Stifel Financial Corp Reata Pharmaceuticals Inc Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $9,823 - $13,065	124 Added 0.83%	14,983 $1.53 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $126,577 - $382,276	4,103 Added 38.15%	14,859 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $13,002 - $24,718	587 Added 5.77%	10,756 $408,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $5,201 - $9,779	-268 Reduced 2.57%	10,169 $256,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $3,044 - $5,365	-147 Reduced 1.39%	10,437 $317,000
Q1 2022 May 13, 2022	BUY	$24.12 - $39.6 $23,975 - $39,362	994 Added 10.36%	10,584 $347,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $888,513 - $3.85 Million	-34,694 Reduced 78.34%	9,590 $253,000
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $47,500 - $67,934	-475 Reduced 1.06%	44,284 $4.46 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $210,076 - $406,062	2,684 Added 6.38%	44,759 $6.33 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $297,076 - $418,617	3,152 Added 8.1%	42,075 $4.2 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $857,256 - $1.55 Million	8,402 Added 27.53%	38,923 $4.81 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $509,644 - $890,039	-5,449 Reduced 15.15%	30,521 $2.97 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $43,699 - $61,089	346 Added 0.97%	35,970 $5.61 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $640,417 - $1.28 Million	5,158 Added 16.93%	35,624 $5.13 Million
Q4 2019 Feb 13, 2020	SELL	$74.57 - $217.92 $45,189 - $132,059	-606 Reduced 1.95%	30,466 $6.21 Million
Q3 2019 Nov 19, 2019	BUY	$71.26 - $95.75 $7,197 - $9,670	101 Added 0.33%	31,072 $2.49 Million
Q3 2019 Nov 13, 2019	BUY	$71.26 - $95.75 $29,786 - $40,023	418 Added 1.37%	30,971 $2.48 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $111,295 - $135,109	-1,432 Reduced 4.48%	30,553 $2.88 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $174,176 - $341,607	3,356 Added 11.72%	31,985 $2.75 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $129,165 - $202,489	-2,649 Reduced 8.47%	28,629 $1.61 Million
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $88,814 - $229,413	2,492 Added 8.66%	31,278 $2.55 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $12,283 - $25,231	616 Added 2.19%	28,786 $997,000
Q1 2018 May 11, 2018	BUY	$20.0 - $30.19 $401,380 - $605,883	20,069 Added 247.73%	28,170 $575,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $181,381 - $269,520	8,101	8,101 $229,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account